Alnylam Pharmaceuticals ALNY
NASDAQ ALNY
$255.36 -0.60 (-0.23%)
At close: Sep 28, 2026 · 4:00 PM EDT

Alnylam Pharmaceuticals (ALNY) Tax Provisions (2009 - 2026)

Updated

Alnylam Pharmaceuticals (ALNY) posted Tax Provisions of $13.31 million for Q2 2026, down 56.9% from $30.92 million a year earlier and down 15.0% from the prior quarter.

Analysis

Alnylam Pharmaceuticals (ALNY) Tax Provisions (2009 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Tax Provisions at Alnylam Pharmaceuticals was -$8.42 million; for FY2025, it came in at $9.41 million.

  • Annual Tax Provisions shows a five-year compound annual growth rate of 28.5% (FY2020 to FY2025).
  • In prior years, Alnylam Pharmaceuticals' Tax Provisions was -$99.22 million in FY2024, $6.73 million in FY2023 (+61.5%), $4.16 million in FY2022 (+512.2%) and $680,000 in FY2021 (-74.6%).
  • Quarterly Tax Provisions has run from a low of -$110.2 million in Q4 2024 to a high of $30.92 million in Q2 2025 over five years.
  • On a year-over-year basis, Tax Provisions increased in two of the last five quarters, with growth averaging 191.2%.
  • The strongest year-over-year quarter for Tax Provisions in the past five years was Q1 2025, with growth of 576.4%; the weakest was Q3 2021, with a decline of 66.9%.
  • According to Business Quant data, Tax Provisions for the three prior quarters was $15.66 million (Q1 2026), -$25.28 million (Q4 2025) and -$12.12 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Johnson & Johnson 653.54 Bn 572.07 Bn 17.26 Bn 1.21 Bn
2 AbbVie 467.01 Bn 440.17 Bn 12.70 Bn 662.00 Mn
3 Merck 367.16 Bn 321.59 Bn 12.21 Bn 654.00 Mn
4 Novartis Ag 277.56 Bn 233.43 Bn 11.24 Bn -1.01 Bn
5 Astrazeneca 258.23 Bn 231.79 Bn 12.86 Bn -291.00 Mn
6 Amgen 224.14 Bn 179.54 Bn 7.24 Bn 393.00 Mn
7 Gilead Sciences 187.30 Bn 161.42 Bn 6.22 Bn 242.00 Mn
8 Pfizer 163.47 Bn 110.41 Bn 10.94 Bn -407.00 Mn
9 Vertex Pharmaceuticals 133.31 Bn 105.31 Bn 2.84 Bn 292.00 Mn
10 Alnylam Pharmaceuticals 34.23 Bn 22.28 Bn 992.69 Mn 13.31 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 13.31 Mn
Mar 31, 2026 15.66 Mn
Dec 31, 2025 -25.28 Mn
Sep 30, 2025 -12.12 Mn
Jun 30, 2025 30.92 Mn
Mar 31, 2025 15.88 Mn
Dec 31, 2024 -110.20 Mn
Sep 30, 2024 2.91 Mn
Jun 30, 2024 5.72 Mn
Mar 31, 2024 2.35 Mn
Dec 31, 2023 183,000.00
Sep 30, 2023 2.99 Mn
Jun 30, 2023 1.82 Mn
Mar 31, 2023 1.74 Mn
Dec 31, 2022 472,000.00
Sep 30, 2022 -23,000.00
Jun 30, 2022 2.73 Mn
Mar 31, 2022 985,000.00
Dec 31, 2021 -1.84 Mn
Sep 30, 2021 278,000.00
API Access

Alnylam Pharmaceuticals Tax Provisions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=tax-provisions&ticker=ALNY&period=max&api_key=YOUR_API_KEY